NCCN Guidelines for Patients® | Myeloproliferative Neoplasms

70 NCCN Guidelines for Patients ® : Myeloproliferative Neoplasms, 2018 NCCN Panel Members NCCN Panel Members for Myeloproliferative Neoplasms Ruben Mesa, MD/Chair Mayo Clinic Cancer Center Catriona Jamieson, MD, PhD/Vice- Chair UC San Diego Moores Cancer Center Ravi Bhatia, MD University of Alabama at Birmingham Comprehensive Cancer Center Michael W. Deininger, MD, PhD Huntsman Cancer Institute at the University of Utah Christopher D. Fletcher, MD University of Wisconsin Carbone Cancer Center Aaron T. Gerds, MD, MS Case Comprehensive Cancer Center/ University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute Ivana Gojo, MD The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Jason Gotlib, MD, MS Stanford Cancer Institute Krishna Gundabolu, MBBS Fred & Pamela Buffett Cancer Center Gabriela Hobbs, MD Massachusetts General Hospital Cancer Center Brandon McMahon, MD University of Colorado Cancer Center Sanjay R. Mohan, MD Vanderbilt-Ingram Cancer Center Stephen Oh, MD, PhD Siteman Cancer Center at Barnes- Jewish Hospital and Washington University School of Medicine Eric Padron, MD Moffitt Cancer Center Nikolaos Papadantonakis, MD, PhD University of Alabama at Birmingham Comprehensive Cancer Center Philip Pancari, MD Fox Chase Cancer Center Nikolai Podoltsev, MD, PhD Yale Cancer Center/ Smilow Cancer Hospital Raajit Rampal, MD, PhD Memorial Sloan Kettering Cancer Center Erik Ranheim, MD, PhD University of Wisconsin Carbone Cancer Center Vishnu Reddy, MD University of Alabama at Birmingham Comprehensive Cancer Center Lindsay A. M. Rein, MD Duke Cancer Institute Bart Scott, MD, MS Fred Hutchinson Cancer Research Center/ Seattle Cancer Care Alliance David S. Snyder, MD City of Hope Comprehensive Cancer Center Brady L. Stein, MD, MHS Robert H. Lurie Comprehensive Cancer Center of Northwestern University Moshe Talpaz, MD University of Michigan Comprehensive Cancer Center Srdan Verstovsek, MD, PhD The University of Texas MD Anderson Cancer Center Martha Wadleigh, MD Dana-Farber/Brigham and Women’s Cancer Center Eunice S. Wang, MD Roswell Park Cancer Institute NCCN Staff Mary Anne Bergman Guidelines Coordinator Hema Sundar, PhD Oncology Scientist Senior Medical Writer For disclosures, visit www.nccn.org/about/disclosure.aspx .

RkJQdWJsaXNoZXIy MTE3MTE1